ColonX
En vente sur le marché américain (selon le DSLD)
XYMOGEN, food supplement from the US market
ColonX (XYMOGEN), a food supplement au code-barres 871149003487, is described by its US market label, recorded on 14 December 2023. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label, entered on 14 December 2023. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Conditions légales
Aloe ferox Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- XYMOGEN
- Barcode
- 871149003487
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Hypromellose, Water, Stearic Acid, Magnesium Stearate, Silica, Medium-Chain Triglyceride Oil
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: ColonX
Entered into DSLD on 23 April 2020. Retirée du marché américain le 8 September 2023 (selon le DSLD).- Active ingredient added : Triphala extract (250 mg)
- Active ingredient removed : Botanical Proprietary Blend (300 mg)
- Active ingredient removed : Triphala Fruit Extract (quantity not stated)
- Different unit, without conversion : Cape Aloe: 50 mg in this version; quantity not stated on the displayed label
Official label: ColonX
Entered into DSLD on 22 October 2016. Retirée du marché américain le 5 November 2018 (selon le DSLD).- Active ingredient added : Triphala extract (250 mg)
- Active ingredient removed : Botanical Proprietary Blend (300 mg)
- Active ingredient removed : Triphala Fruit Extract (quantity not stated)
- Different unit, without conversion : Cape Aloe: 50 mg in this version; quantity not stated on the displayed label
Official label: ColonX
Entered into DSLD on 25 August 2015. Retirée du marché américain le 5 October 2016 (selon le DSLD).- Active ingredient added : Emblica officinalis (quantity not stated)
- Active ingredient added : Terminalia belerica (quantity not stated)
- Active ingredient added : Terminalia chebula (quantity not stated)
- Active ingredient added : Triphala extract (75 mg)
- Active ingredient removed : Botanical Proprietary Blend (300 mg)
- Active ingredient removed : Triphala Fruit Extract (quantity not stated)
- Different unit, without conversion : Cape Aloe: 300 mg in this version; quantity not stated on the displayed label
Official label: ColonX
Entered into DSLD on 25 April 2014. Retirée du marché américain le 26 February 2015 (selon le DSLD).- Active ingredient added : Triphala Extract {Blend} (75 mg)
- Active ingredient removed : Botanical Proprietary Blend (300 mg)
- Active ingredient removed : Triphala Fruit Extract (quantity not stated)
- Different unit, without conversion : Cape Aloe: 300 mg in this version; quantity not stated on the displayed label
Official label: ColonX
Entered into DSLD on 23 March 2012. Retirée du marché américain le 8 October 2012 (selon le DSLD).- Active ingredient added : Triphala Extract (75 mg)
- Active ingredient removed : Botanical Proprietary Blend (300 mg)
- Active ingredient removed : Triphala Fruit Extract (quantity not stated)
- Different unit, without conversion : Cape Aloe: 300 mg in this version; quantity not stated on the displayed label
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : XYMOGEN